On the other hand, several studies have shown that TLR3 agonist poly I:C pretreatment can improve the therapeutic effect of umbilical cord mesenchymal stem cells in dextran sulphate sodium (DSS)-induced colitis [90,91,92]. Here, TLR3 is linked to colitis.